MET Stock Analysis: Buy, Sell, or Hold?
MET - MetLife, Inc.
$94.34
0.88 (0.94%)
â˛
5d:
-3.4%
30d:
+1.95%
90d:
+11.91%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 05, 2026
0d
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Aug 20, 2026 at $94.34 · last confirmed Aug 20, 2026
Strength: 4.5/10
Get Alerted When MET Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MET is fairly priced but lacks strong directional signals. At 4.7% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MET is fairly priced but lacks strong directional signals. At 4.7% expected growth, valuation appears stretched. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$117.18
Based on 7.5% avg growth
INTRINSIC VALUE TODAY
$72.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MET is currently trading at $94.34, which is considered slightly low relative to its 30-day fair value range of $93.50 to $97.41. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.7) compared to its historical average (7.5). At these levels, the market is pricing in 4.7% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MET is in a strong uptrend. The price is currently testing key support at $93.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MET scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $104.38 (+10.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MET is in a strong uptrend. The price is currently testing key support at $93.37. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MET scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $104.38 (+10.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$93.50 -
$97.41
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
53.8%
Protect Your Profits
Holding MET? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (34/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($104.38)
- NEUTRAL: Trading at premium valuation - market expects 4.7% growth which is achievable
- WARNING: Composite score 36/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$93.50 -
$97.41
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$93.37
Resistance Level
$98.58
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.66
Wall Street Target
$104.38
(+10.6%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
5.8%
Profit Margin
4.6%
Valuation Premium vs History
+4.7% premium
PE vs Historical
8.7 vs 7.5
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.7%
(market-implied from PE analysis)
1-Year Target
$98.77
(+5%)
2-Year Target
$103.42
(+10%)
3-Year Target
$108.28
(+15%)
3-Yr Target (if PE normalizes)
(PE: 9â8)
PE COMPRESSION
$93.81
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 11.0%)
$299.42
(+217%)
Base:
(SPY PE: 8.7, Growth: 11.0%)
$129.15
(+37%)
Bear:
(PE: 7.4, Growth: 11.0%)
$109.78
(+16%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (18x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 18.22 | Current EPS (TTM): $5.13
Bull Case
$205.61
(+118%)
Analyst growth 100.0%, PE expands to 20.0
Base Case
$186.92
(+98%)
Market implied 100.0%, PE stable at 18.2
Bear Case
$63.55
(-33%)
Severe decline -20.0%, PE contracts to 15.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 22, 2026 9:46 PM ET
Data refreshes hourly during market hours. Next update: 10:46 PM
Data refreshes hourly during market hours. Next update: 10:46 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MET showing a specific setup today?
Insider Activity (6 Months)
2
Buys
2
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Ro Khanna
BUY
2026-03-10
Top Rated Insurance - Life Stocks
Top-rated stocks in Insurance - Life by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
UNM
Unum Group |
BUY
13 analysts |
$101 | 53 HOLD |
|
ABL
Abacus Life Inc. |
STRONG BUY
5 analysts |
$14 | 42 HOLD |
|
MFC
Manulife Financial Corp |
BUY
13 analysts |
$34 | 33 SELL |
|
GL
Globe Life Inc |
BUY
10 analysts |
$194 | 33 SELL |
|
AFL
Aflac Incorporated |
SELL
14 analysts |
$119 | 51 HOLD |
Advanced MET Option Strategies
Professional options setups generated by AI based on today's MET price and gamma walls.
